Skip to main content
Fig. 2 | Alzheimer's Research & Therapy

Fig. 2

From: Beyond expectations: investigating nilotinib’s potential in attenuating neurodegeneration in Alzheimer’s disease

Fig. 2

Reprinted from “Alzheimer’s Disease (AD) Treatment Model,” by BioRender.com (2024). Retrieved from https://app.biorender.com/biorender-templates/figures. Showing the most common drugs used in the treatment of AD; memantine functioning on the NMDA receptor and donepezil, galantamine, and rivastigmine working on acetylcholinesterase. Not pictured are the newest class of drugs, monoclonal antibodies, that target amyloid to decrease Aβ plaque burden

Back to article page

Alzheimer's Research & Therapy

ISSN: 1758-9193